Zusammenfassung
Derzeit beträgt die perioperative Letalität in der Koronar- und Herzklappenchirurgie etwa 3 %. Diese deutliche Verbesserung wird zum einen durch eine Optimierung der operativen Technik und des Myokardschutzes sowie die Fortschritte in der Anästhesiologie erreicht. Dieses Kapitel gibt einen Überblick über die Besonderheiten kardiochirurgischer Patienten, wichtige Aspekte in der präoperativen Betreuung sowie die Anästhesieführung per se, wobei auf die Besonderheiten unterschiedlicher kardiochirurgischer Eingriffe eingegangen wird.
Literatur
Gibbon JH (1954) Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med 37:171
Noyez L, Janssen DP, van Druten JA et al (1998) Coronary bypass surgery: what is changing? Analysis of 3834 patients undergoing primary isolated myocardial revascularization. Eur J Cardiothorac Surg 13:365–369
Funkat A, Beckmann A, Lewandowski J et al (2014) Cardiac surgery in Germany during 2013: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 62:380–392
Van Aken H, Ender J, Heringlake M et al (2015) Personelle, räumliche und organisatorische Voraussetzungen sowie Anforderungen bei der Erbringung von Anästhesieleistungen bei herzchirurgischen und interventionellen kardiologischen Eingriffen. Anästhesiol Intensivmed 56:99–103
Grabitz K, Ommer A, Schmitt HH et al (2001) Simultane operative Behandlung von A.-carotis-interna-Stenosen und koronare Herzerkrankung. Dtsch Med Wochenschr 126:485–490
Hill AB, Obrand D, O’Rourke K et al (2000) Hemispheric stroke following cardiac surgery: a case-control estimate of the risk resulting from ipsilateral asymptomatic carotid artery stenosis. Ann Vasc Surg 14:200–209
Li Y, Walicki D, Mathiesen C et al (2009) Strokes after cardiac surgery and relationship to carotid stenosis. Arch Neurol 66(9):1091–1096
Schmidt M, Scheunert T, Steinbach G et al (2001) Hypertension as a risk factor for cerebral injury during cardiopulmonary bypass. Anaesthesia 56:733–738
Brabant SM, Bertrand M, Eyraud D et al (1999) The hemodynamic effect of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists. Anesth Analg 88:1388–1392
Bertrand M, Godet G, Meersschaert K et al (2001) Should the angiotensin II antagonist be discontinued before surgery? Anesth Analg 92:26–30
Smetana GW (1999) Preoperative pulmonary evaluation. N Engl J Med 340:937–944
Loer SA, Kalweit G, Tarnow J (2000) Effects of ventilation and nonventilation on pulmonary venous blood gases and markers of lung hypoxia in humans undergoing total cardiopulmonary bypass. Crit Care Med 28:1336–1340
Warner MA, Offord KP, Warner ME et al (1989) Role of preoperative cessation of smoking and other factors in postoperative pulmonary complications: a blinded prospective study of coronary artery bypass patients. Mayo Clin Proc 64:609–616
Turan A, Mascha EJ, Roberman D et al (2011) Smoking and perioperative outcomes. Anesthesiology 114:837–846
Novis BK, Roizen MF, Aronson S et al (1994) Association of preoperative risc factors with postoperative acut renal failure. Anesth Analg 78:143–149
Magee MJ, Dewey TM, Acuff T et al (2001) Influence of diabetes on mortality and morbidity: off-pump coronary artery bypass grafting vs. coronary artery bypass grafting with cardiopulmonary bypass. Ann Thorac Surg 72:776–781
Furnary AP, Gao G, Grunkemeier GL et al (2003) Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary bypass grafting. J Thorac Cardiovasc Surg 125:1007–1021
Quattara A, Lecomte P, Manach YL et al (2005) Poor intraoperative blood glucose control is associated with worsened hospital outcome after cardiac surgery in diabetic patient. Anesthesiology 103:687–694
Fleisher LA, Fleischmann KE, Auerbach AD et al (2015) 2014 ACC/AHA guidelines on periperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary. J Nucl Cardiol 22:162–215
ten Broecke PWC, De Hert SG, Mertens E et al (2003) Effect of preoperative β-blockade on perioperative mortality in coronary surgery. Br J Anaesth 90:27–31
Slogoff S, Keats AS (1989) Randomized trial of primary anesthetic agents on outcome of coronary artery bypass operations. Anesthesiology 70:179–188
Tuman KJ, McCarthy RJ, Spiess BD et al (1989) Does choice of anesthetic agent significantly affect outcome after coronary artery surgery? Anesthesiology 70:189–198
Molenaar N, Bijkerk RM, Beishuizen A et al (2012) Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate. Crit Care 16:R121
Heinrich S, Schmidt J, Ackermann A et al (2014) Comparison of clinical outcome variables in patients with and without etomidate-facilitated anesthesia induction ahead of major cardiac surgery: a retrospective analysis. Crit Care 18:R150
Kowalski C, Zahler S, Becker BF et al (1997) Halothane, isoflurane and sevoflurane reduce postischemic adhesion of neutrophils in the coronary system. Anesthesiology 86:188–195
Cromheecke S, Pepermans V, Hendrickx E et al (2006) Cardioprotective properties of sevoflurane in patients undergoing aortic valve replacement with cardiopulmonary bypass. Anesth Analg 103:289–296
De Hert SG (2004) Cardioprotection with volatile anesthetics: clinical relevance. Curr Opin Anaesthesiol 17:57–62
Symons JA, Myles PS (2006) Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis. Br J Anaesth 97:127–136
Landoni G, Biondi-Zoccai GGL, Zangrillo A et al (2007) Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 21:502–511
Kaplan JA, King SB (1976) The precordial electrocardiographic lead (V5) in patients who have coronary artery disease. Anesthesiology 45:570–574
Carl M, Alms A, Braun J et al (2010) S3-Leitlinie zur intensivmedizinischen Versorgung herzchirurgischer Patienten. Hämodynamisches Monitoring und Herz/Kreislauf. AWMF-Register 001/016. www.awmf-org
Stern DH, Gerson JI, Allen FB et al (1985) Can we trust the direct radial artery pressure immediatly following cardiopulmonary bypass? Anesthesiology 62:557–561
Cohen DJ, van Hout B, Serruys PW, for the SYNTAX Investigators et al (2011) Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery. N Engl J Med 364:1016–1026
Ranucci M (2006) Which cardiac surgical patient can benefit from placement of a pulmonary artery catheter? Crit Care 10(Suppl 3):S6
Tuman KJ, Mc Carthy RJ, Spiess BD et al (1989) Effect of pulmonary artery catheterization on outcome in patients undergoing coronary artery surgery. Anesthesiology 70:199–206
Schmid ER, Bürki C, Engel MHC et al (1999) Inhaled nitric oxide vs. intravenous vasodilators in severe pulmonary hypertension after cardiac surgery. Anesth Analg 89:1108–1115
Miller JP, Lambert AS, Shapira WA et al (2001) The adequancy of basic intraoperative tranesophageal echocardiography performed by experienced anesthesiologists. Anesth Analg 92:1103–1110
Schroder JN, Williams ML, Hata JA et al (2005) Impact of mitral valve regurgitation evaluated by intraoperative transesophageal echocardiography on long-term outcomes after coronary artery bypass grafting. Circulation 112(9 Suppl):I293–298
Greim CA, Schmidt C, Schirmer U et al (2011) Aktuelle Empfehlungen zum perioperativen Einsatz der transösophagealen Echokardiografie in der Anästhesiologie. Anästhesiol Intensivmed 52:73–76
Hahn RT, Abraham T, Adams MS et al (2014) Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. Anesth Analg 118:921–968
Murkin JM, Adams SJ, Novick RJ et al (2007) Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study. Anesth Analg 104:51–58
du Plessis AJ, Jonas RA, Wypij D et al (1997) Perioperative effects of alpha-stat vs. pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants. J Thorac Cardiovasc Surg 114:991–1000
Fox AA, Marcantonio ER, Collard CD et al (2011) Increased peak postoperative b-type natriuretic peptide predicts decreased longer-term physical function after primary coronary artery bypass graft surgery. Anesthesiology 114:807–816
Mangoush O, Purkayastha S, Haj-Yahia S et al (2007) Heparin-bonded circuits versus nonheparin-bonded circuits: an evaluation of their effect on clinical outcomes. Eur J Cardiothorac Surg 31:1058–1069
Welsby IJ, Newman MF, Phillips-Bute B et al (2005) Hemodynamic changes after protamine administration. Anesthesiology 102:308–314
Warkentin TE, Greinacher A (2003) Heparin induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 76:638–648
Dyke CM, Koster A, Vale JJ et al (2005) Preemptive use of bivalirudin for urgent on-pump coronary artery bypass grafting in patients with potential heparin-induced thrombocytopenia. Ann Thorac Surg 80:299–303
Dyke CM, Smedira NG, Koster A et al (2006) A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study. J Cardiovasc Surg 131:533–539
Murphy GS, Marymont JH (2007) Alternative anticoagulation management strategies for patients with heparin-induced thrombocytopenia undergoing cardiac surgery. J Cardiothorac Vasc Anesth 21:113–126
Shinoka T, Shum-Tim D, Laussen PC et al (1998) Relative roles of colloid oncotic pressure and hemotocrit in determining outcome after deep hypothermic circulatory arrest. Ann Thorac Surg 65:155–164
Sade RM, Stoud MR, Crawford FAJ et al (1985) A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringers solution as priming fluid for cardiopulmonary bypass. J Thorac Cardiovasc Surg 89:713–722
Anderson L, Quasim I, Soutar R et al (2006) An audit of red cell and blood product use after institution of thrombelstometry in a cardiac intensive care unit. Transfus Med 16:31–39
Cammerer U, Dietrich W, Rampf T et al (2003) The predictive value of modified computerized thrombelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg 96:51–57
Schlitt A, Jambor J, Spannagl M et al (2013) Perioperativer Umgang mit Antikoagulantien und Thrombozytenaggregationshemmern. Dtsch Arztebl Int 101(31–32):525–532
Van Veen JJ, Makris M (2015) Management of peri-operative anti-thrombotic therapy. Anaesthesia 70(Suppl 1):58–67
Kaneko T, Yammine M, Aranki SF (2014) New oral anticoagulants – what the cardiothoracic surgeon needs to know. J Thorac Cardiovasc Surg 148:1794–1801
Dietrich W (2000) Cardiac surgery and the coagulation system. Curr Opin Anaesthesiol 13:27–34
Mongan PD, Brown RS, Thwaites BK (1998) Tranexamic acid and aprotinin reduce postoperative bleeding and transfusions during primary coronary revascularisation. Anesth Analg 87:258–265
Munoz JJ, Birkmeyer NJO, Birkmeyer JD et al (1999) Is aminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery? Circulation 99:81–89
Fergusson DA, Hebert PC, Mazer CD et al (2008) A comparison of aprotinin and lysin analogues in high-risk cardiac surgery. N Engl J Med 358:2319–2331
Hiatt WR (2006) Observational studies of drug safety – aprotinin and the absence of transparency. N Engl J Med 355:2171–2173
Mangano DT, Tudor IC, Dietzel C et al (2006) The risk associated with aprotinin in cardiac surgery. N Engl J Med 354:353–365
Carrascal Y, Guerrero AL (2010) Neurological damage related to cardiac surgery. Neurologist 16:152–164
Hartman GS, Yao F-S, Bruefach M et al (1996) Severity of aortic atheromatous disease diagnosed by transesophageal echocardiography predicts stroke and other outcomes associated with coronary artery surgery: a prospective study. Anesth Analg 83:701–708
Davila-Roman VG, Kouchoukos NT, Schechtman KB et al (1999) Atherosclerosis of the ascending aorta is a predictor of renal dysfunction after cardiac operations. J Thorac Cardiovasc Surg 117:111–116
Zacharias M, Conlon NP, Herbison GP et al (2008) Interventions for protecting renal function in the perioperative period. Cochrane Database Syst Rev (4):CD003590
Rady MY, Ryan T, Starr NJ (1997) Early onset of acute pulmonary dysfunction after cardiovascular surgery: risk factors and clinical outcome. Crit Care Med 25:1831–1839
Kilger E, Weis FC, Goetz AE et al (2001) Intensive care after minimally invasive and conventional coronary surgery: a prospective comparison. Intensive Care Med 27:534–539
Oliver WC, Nuttall GA, Orszulak TA et al (2004) Hemofiltration but not steroids results in earlier tracheal extubation following cardiopulmonary bypass. Anesthesiology 101:327–339
Chello M, Patti G, Candura D et al (2006) Effect of atorvastin on systemic inflammatory response after coronary bypass surgery. Crit Care Med 34:660–667
Walther A, Bardenheuer HJ (1998) Intraoperative Gabe von Calcium. Anaesthesist 47:339–347
Miller S, Crystal E, Garfinkle M et al (2005) Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis. Heart 91:618–623
Möhnle P, Goetz AE (2001) Physiologische Effekte, Pharmakologie und Indikationen zur Gabe von Magnesium. Anästhesist 50:377–391
Shrivastava R, Smith B, Caskey D et al (2009) Atrial fibrillation after cardiac surgery: does prophylactic therapy decrease adverse outcomes associated with atrial fibrillation. J Intensive Care Med 24:18–25
Landoni G, Mizzi A, Biondi-Zoccai G et al (2010) Reducing mortality in cardiac surgery with levosimendan: a meta-analysis of randomized controller trials. J Cardiothorac Vasc Anesth 24:51–57
Maharaj R, Metaxa V (2011) Levosimendan and mortality after coronary revascularisation: a meta-analysis of randomised controlled trials. Crit Care 15:R140
Dünser MW, Mayr AJ, Ulmer H et al (2001) The effect of vasopressin on systemic hemodynamic in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg 93:7–13
Creswell LL, Rosenbloom M, Cox JL et al (1992) Intraaortic balloon counterpulsation: patterns of usage and outcome in cardiac surgery patients. Ann Thorac Surg 54:11–20
Hamm CW, Reimers J, Ischinger T, GABI Trial Group et al (1994) A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. N Engl J Med 331:1037–1043
King SB III, Lembo NJ, Weintraub WS, EAST Trial Group et al (1994) A randomized trial comparing coronary angioplasty with coronary bypass surgery. N Engl J Med 331:1044–1050
Fitzgibbon GM, Kafka HP, Leach AJ et al (1996) Coronary bypass graft fate and patient outcome: angiographic follow-up of 5065 grafts related to survival and reoperation in 1388 patients during 25 years. J Am Coll Cardiol 28:616–626
Liu SS, Block BM, Wu CL (2004) Effects of perioperative central neuroaxial analgesia on outcome after coronary artery bypass surgery. Anesthesiology 101:153–161
Candilio L, Malik A, Ariti C et al (2015) Effect of remote ischaemic precondition on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial. Heart 101:185–192
Hachenberg T, Möllhoff T, Holst D et al (1997) Cardiopulmonary effects of enoximone or dobutamine and nitroglycerin on mitral valve regurgitation and pulmonary hypertension. J Cardiothorac Anesth 11:453–457
Zwißler B (2000) Das akute Rechtsherzversagen. Anaesthesist 49:788–808
Maron BJ, Roberts WC, McAllister HA et al (1980) Sudden death in young athlets. Circulation 62:218–229
Lamy A, Devereaux PJ, Prabhakaran D et al (2013) Effects of off-pump and on-pump coronary-artery bypass grafting at 1 year. N Engl J Med 368:1179–1188
Leon MB, Smith CR, Mack M et al (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607
Panchal HB, Ladia V, Desai S et al (2013) A meta-analysis of mortality and major cardiovascular and cerebrovascular events following transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis. Am J Cardiol 112:850–860
Mauri L, Foster E, Glower DD et al (2013) 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. J Am Coll Cardiol 62:317–328
Fann JI, Pompili MF, Stevens JH et al (1997) Port-access cardiac operations with cardiplegic arrest. Ann Thorac Surg 63:S35–S39
Kessler P, Lischke V, Westphal K (2000) Anästhesiologische Besonderheiten bei minimal-invasiver Herzchirurgie. Anaesthesist 49:592–608
Zwißler B (2000) Minimal invasive Herzchirurgie – Herausforderung und Chance für die Anästhesie. Anaesthesist 49:587–589
Lund LH, Edwards LB, Kucheryavaya AY et al (2014) The registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report – 2014. J Heart Lung Transplant 33:996–1008
Braun S, Schrötter H, Schmeisser A et al (2007) Evaluation of pulmonary vascular response in inhaled iloprost in heart transplant candidates with pulmonary venous hypertension. Int J Cardiol 115:67–72
Chen EP, Bittner HB, Davis RD et al (1998) Hemodynamic and inotropic effects of milrinone after heart transplantation in the setting of recepient pulmonary hypertension. J Heart Lung Transplant 17:669–678
Augoustides JGT, Riha H (2009) Recent progress in heart failure treatment and heart transplantation. J Cardiothorac Vasc Anesth 23:738–748
Auler JOC, Carmona MJC, Bocchi EA et al (1996) Low doses of inhaled nitric oxide in heart transplant recipients. J Heart Lung Transplant 15:443–450
Sablotzki A, Hentschel T, Hofmann S et al (2006) Inhaled aerosolized iloprost in the evaluation of heart transplant candidates – experients with 45 cases. J Clin Anesth 18:108–113
Engin C, Ayik F, Oguz E et al (2011) Ventricular assist device as a bridge to heart transplantation in adults. Transplant Proc 43:927–930
Markewitz A (2013) Jahresbericht 2011 des deutschen Herzschrittmacher- und Defibrillatorregisters. Herzschrittmacherther Elektrophysiol 24:223–248
Ho JK, Mahajan A (2010) Cardiac resynchronisation therapy for treatment of heart failure. Anesth Analg 111:1353–1361
Bardy GH, Smith WM, Hood MA et al (2010) An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med 363:36–44
Gutsche JT, Feinman J, Silvay G et al (2014) Practice variations in the conduct of hypothermic circulatory arrest for adult aortic arch repair: focus on an emerging European paradigm. Heart Lung Vessel 6:43–51
Shenaq SA, Svensson LG (1993) Paraplegia following aortic surgery. J Cardiothorac Anesth 7:81–94
Bratton SL, Ramamoorthy C, Eck JB et al (1998) Teaching successful central venous cannulation in infants and children: audio Doppler vs. anatomic landmarks. J Cardiothorac Anesth 12:523–526
Flori HR, Johnson LD, Hanley FL et al (2000) Transthoracic intracardiac catheters in pediatric patients recovering from congenital heart defect surgery: associated complications and outcomes. Crit Care Med 28:2997–3001
Little LA, Koenig JC, Newth CJL (1990) Factors affecting accidental extubation in neonatal and pediatric intensive care patients. Crit Care Med 18:163–165
Steven JM, McGowan FX (2000) Neuraxial blockade for pediatric cardiac surgery: lessons yet to be learned. Anesth Analg 90:1011–1013
Chauhan S, Bisoi A, Kumar N et al (2004) Dose comparison of tranexamic acid in pediatric cardiac surgery. Asian Cardiovasc Thorac Ann 12:121–124
Chauhan S, Kumar BA, Rao BH et al (2000) Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. Ann Thorac Surg 70:1308–1312
Laussen PC, Reid RW, Stene RA et al (1996) Tracheal extubation of children in the operating room after atrial septal defect repair as a part of a clinical practice guideline. Anesth Analg 82:988–993
Carminati M, Giusti S, Hausdorf G et al (2000) A European multicentric experience using the CardioSeal and Starflex double umbrella devices to close interatrial communications holes within the oval fossa. Cardiol Young 10:519–526
Morris K, Beghetti M, Petros A et al (2000) Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Crit Care Med 28:2974–2978
Ohye RG, Sleeper LA, Mahony L et al (2010) Comparison of shunt types in the Norwood procedure for single-ventricle lesions. N Engl J Med 362:1980–1992
Imanaka H, Miyano H, Takeuchi M et al (2000) Effects of nitric oxide inhalation after pulmonary thromboendarterectomy for chronic pulmonary thromboembolism. Chest 118:39–47
Klotz S, Loehr A, Drees G et al (2006) Chirurgische Therapie der Herzinsuffizienz. Herz 31:445–454
Batista RJV, Verde J, Nery P et al (1997) Partial left ventriculectomy to treat end-stage heart disease. Ann Thorac Surg 64:634–638
Frommelt PC, Snider AR, Meliones JN et al (1991) Doppler assesment of pulmonary artery flow patterns and ventricular function after the Fontan operation. Am J Cardiol 68:1211–1215
Schwartz AJ, Campbell FW III (1998) Pathophysiological approach to congenital heart disease. In: Lake CL (Hrsg) Pediatric cardiac anesthesia. Appleton & Lange, Stamford
Seitz W, Lübbe N, Schaps D et al (1991) Propofol zur Einleitung und Aufrechterhaltung der Hypnose bei koronarchirurgischen Eingriffen. Anästhesist 40:145–152
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2015 © Springer-Verlag GmbH Deutschland
About this entry
Cite this entry
Kowalski, C., Zwißler, B. (2015). Anästhesie in der Chirurgie des Herzens und der herznahen Gefäße. In: Rossaint, R., Werner, C., Zwißler, B. (eds) Die Anästhesiologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45539-5_74-1
Download citation
DOI: https://doi.org/10.1007/978-3-662-45539-5_74-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-45539-5
Online ISBN: 978-3-662-45539-5
eBook Packages: Springer Referenz Medizin